These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34112113)

  • 1. Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
    Christensen SF; Scherber RM; Mazza GL; Dueck AC; Brochmann N; Andersen CL; Hasselbalch HC; Mesa RA; Geyer HL
    BMC Cancer; 2021 Jun; 21(1):691. PubMed ID: 34112113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms with Relation to Genetic Burden and Thrombosis.
    Ümit EG; Baysal M; Kırkızlar HO; Demir AM
    Turk J Haematol; 2024 Aug; 41(3):175-181. PubMed ID: 38801033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
    Emanuel RM; Dueck AC; Geyer HL; Kiladjian JJ; Slot S; Zweegman S; te Boekhorst PA; Commandeur S; Schouten HC; Sackmann F; Kerguelen Fuentes A; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Doehner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Birgegard G; Tefferi A; Mesa RA
    J Clin Oncol; 2012 Nov; 30(33):4098-103. PubMed ID: 23071245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies.
    Mazza GL; Kunze KL; Langlais BT; Kosiorek HE; DeWees TA; Geyer HL; Scherber RM; Mesa RA; Dueck AC
    Leuk Lymphoma; 2019 Jul; 60(7):1789-1795. PubMed ID: 30652523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.
    Gowin K; Langlais BT; Kosiorek HE; Dueck A; Millstine D; Huberty J; Eckert R; Mesa RA
    Cancer Med; 2020 Dec; 9(24):9445-9453. PubMed ID: 33140580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition.
    Padrnos L; Scherber R; Geyer H; Langlais BT; Dueck AC; Kosiorek HE; Senyak Z; Clark M; Boxer M; Cotter M; Harrison C; Stonnington C; Geda Y; Mesa R
    Cancer Med; 2020 Nov; 9(22):8301-8309. PubMed ID: 32976697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark.
    Brochmann N; Flachs EM; Christensen AI; Bak M; Andersen CL; Juel K; Hasselbalch HC; Zwisler AD; Rottmann N
    Clin Epidemiol; 2019; 11():23-33. PubMed ID: 30588121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls.
    Anderson LA; James G; Duncombe AS; Mesa R; Scherber R; Dueck AC; de Vocht F; Clarke M; McMullin MF
    Am J Hematol; 2015 Oct; 90(10):864-70. PubMed ID: 26113113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco Smoking and Psychotic-Like Experiences in a General Population Sample.
    Mallet J; Mazer N; Dubertret C; Le Strat Y
    J Clin Psychiatry; 2018 Oct; 79(6):. PubMed ID: 30289630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tobacco smoking on outcomes after left ventricular assist device implantation.
    Combs P; Imamura T; Siddiqi U; Spiller RE; Williamson R; Mirzai S; Symalla T; LaBuhn C; Jeevanandam V
    Artif Organs; 2020 Jul; 44(7):693-699. PubMed ID: 32017136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center.
    Grubb AF; Pumill CA; Greene SJ; Wu A; Chiswell K; Mentz RJ
    Am Heart J; 2020 Dec; 230():25-34. PubMed ID: 32980363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
    Geyer HL; Andreasson B; Kosiorek HE; Dueck AC; Scherber RM; Martin KA; Butler KA; Harrison CN; Radia DH; Cervantes F; Kiladjian JJ; Reiter A; Birgegard G; Passamonti F; Senyak Z; Vannucchi AM; Paoli C; Xiao Z; Samuelsson J; Mesa RA
    Cancer; 2016 Jun; 122(12):1888-96. PubMed ID: 27070130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the MPN Landmark survey for impact and perceptions of treatment goals among Chinese physicians and myeloproliferative neoplasm patients].
    Xu ZF; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):570-575. PubMed ID: 32810964
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms.
    Johansson P; Mesa R; Scherber R; Abelsson J; Samuelsson J; Birgegård G; Andréasson B
    Leuk Lymphoma; 2012 Mar; 53(3):441-4. PubMed ID: 21883029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms.
    Abelsson J; Andréasson B; Samuelsson J; Hultcrantz M; Ejerblad E; Johansson B; Emanuel R; Mesa R; Johansson P
    Leuk Lymphoma; 2013 Oct; 54(10):2226-30. PubMed ID: 23398206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between smoking status and bodily pain in a cross-sectional survey of UK respondents.
    Perski O; Garnett C; Shahab L; Brown J; West R
    Addict Behav; 2020 Mar; 102():106229. PubMed ID: 31862683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
    Geyer HL; Kosiorek H; Dueck AC; Scherber R; Slot S; Zweegman S; Te Boekhorst PA; Senyak Z; Schouten HC; Sackmann F; Fuentes AK; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Döhner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Paoli C; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Cannon K; Birgegard G; Xiao Z; Xu Z; Zhang Y; Sun X; Xu J; Kiladjian JJ; Zhang P; Gale RP; Mesa RA
    Haematologica; 2017 Jan; 102(1):85-93. PubMed ID: 27540137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN.
    Harrison C; Mathias J; Campbell-Drew M; Mead AJ; Pemberton-Whiteley Z; Ali S; Wadelin F; Taylor-Stokes G; Waller J; Taylor B
    Br J Haematol; 2019 Aug; 186(3):e1-e4. PubMed ID: 30854625
    [No Abstract]   [Full Text] [Related]  

  • 19. Disabled, invisible and dismissed-The lived experience of fatigue in people with myeloproliferative neoplasms.
    Bradford A; Young K; Whitechurch A; Burbury K; Pearson EJM
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1655. PubMed ID: 35705529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?
    Langlais BT; Geyer H; Scherber R; Mesa RA; Dueck AC
    Leuk Lymphoma; 2019 Feb; 60(2):402-408. PubMed ID: 30033837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.